360 related articles for article (PubMed ID: 25470448)
1. Loss of SH3 domain-binding protein 2 function suppresses bone destruction in tumor necrosis factor-driven and collagen-induced arthritis in mice.
Mukai T; Gallant R; Ishida S; Kittaka M; Yoshitaka T; Fox DA; Morita Y; Nishida K; Rottapel R; Ueki Y
Arthritis Rheumatol; 2015 Mar; 67(3):656-67. PubMed ID: 25470448
[TBL] [Abstract][Full Text] [Related]
2. SH3BP2 gain-of-function mutation exacerbates inflammation and bone loss in a murine collagen-induced arthritis model.
Mukai T; Gallant R; Ishida S; Yoshitaka T; Kittaka M; Nishida K; Fox DA; Morita Y; Ueki Y
PLoS One; 2014; 9(8):e105518. PubMed ID: 25144740
[TBL] [Abstract][Full Text] [Related]
3. SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss.
Mukai T; Ishida S; Ishikawa R; Yoshitaka T; Kittaka M; Gallant R; Lin YL; Rottapel R; Brotto M; Reichenberger EJ; Ueki Y
J Bone Miner Res; 2014 Dec; 29(12):2618-35. PubMed ID: 24916406
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of sorting nexin 10 prevents bone erosion in collagen-induced mouse arthritis through promoting NFATc1 degradation.
Zhou C; You Y; Shen W; Zhu YZ; Peng J; Feng HT; Wang Y; Li D; Shao WW; Li CX; Li WZ; Xu J; Shen X
Ann Rheum Dis; 2016 Jun; 75(6):1211-8. PubMed ID: 26141367
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study.
Kato G; Shimizu Y; Arai Y; Suzuki N; Sugamori Y; Maeda M; Takahashi M; Tamura Y; Wakabayashi N; Murali R; Ono T; Ohya K; Mise-Omata S; Aoki K
Arthritis Res Ther; 2015 Sep; 17(1):251. PubMed ID: 26373710
[TBL] [Abstract][Full Text] [Related]
6. Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ Osteoclasts.
Kittaka M; Mayahara K; Mukai T; Yoshimoto T; Yoshitaka T; Gorski JP; Ueki Y
J Bone Miner Res; 2018 Jan; 33(1):167-181. PubMed ID: 28914985
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis.
Nakasa T; Shibuya H; Nagata Y; Niimoto T; Ochi M
Arthritis Rheum; 2011 Jun; 63(6):1582-90. PubMed ID: 21425254
[TBL] [Abstract][Full Text] [Related]
8. Increased chemotaxis and activity of circulatory myeloid progenitor cells may contribute to enhanced osteoclastogenesis and bone loss in the C57BL/6 mouse model of collagen-induced arthritis.
Ikić Matijašević M; Flegar D; Kovačić N; Katavić V; Kelava T; Šućur A; Ivčević S; Cvija H; Lazić Mosler E; Kalajzić I; Marušić A; Grčević D
Clin Exp Immunol; 2016 Dec; 186(3):321-335. PubMed ID: 27612450
[TBL] [Abstract][Full Text] [Related]
9. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor-transgenic mice.
Schurigt U; Hummel KM; Petrow PK; Gajda M; Stöckigt R; Middel P; Zwerina J; Janik T; Bernhardt R; Schüler S; Scharnweber D; Beckmann F; Saftig P; Kollias G; Schett G; Wiederanders B; Bräuer R
Arthritis Rheum; 2008 Feb; 58(2):422-34. PubMed ID: 18240253
[TBL] [Abstract][Full Text] [Related]
11. CARD11 blockade suppresses murine collagen-induced arthritis via inhibiting CARD11/Bcl10 assembly and T helper type 17 response.
Wang H; Zhao J; Zhang H; Huang Y; Wang S; Tu Q; Yang N
Clin Exp Immunol; 2014 May; 176(2):238-45. PubMed ID: 24443940
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice.
Geboes L; Dumoutier L; Kelchtermans H; Schurgers E; Mitera T; Renauld JC; Matthys P
Arthritis Rheum; 2009 Feb; 60(2):390-5. PubMed ID: 19180498
[TBL] [Abstract][Full Text] [Related]
13. A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis.
Saito H; Kojima T; Takahashi M; Horne WC; Baron R; Amagasa T; Ohya K; Aoki K
Arthritis Rheum; 2007 Apr; 56(4):1164-74. PubMed ID: 17393436
[TBL] [Abstract][Full Text] [Related]
14. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
15. Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis.
Kelchtermans H; Geboes L; Mitera T; Huskens D; Leclercq G; Matthys P
Ann Rheum Dis; 2009 May; 68(5):744-50. PubMed ID: 18480308
[TBL] [Abstract][Full Text] [Related]
16. Osteoclast-Derived Autotaxin, a Distinguishing Factor for Inflammatory Bone Loss.
Flammier S; Peyruchaud O; Bourguillault F; Duboeuf F; Davignon JL; Norman DD; Isaac S; Marotte H; Tigyi G; Machuca-Gayet I; Coury F
Arthritis Rheumatol; 2019 Nov; 71(11):1801-1811. PubMed ID: 31162832
[TBL] [Abstract][Full Text] [Related]
17. Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice.
Ueki Y; Lin CY; Senoo M; Ebihara T; Agata N; Onji M; Saheki Y; Kawai T; Mukherjee PM; Reichenberger E; Olsen BR
Cell; 2007 Jan; 128(1):71-83. PubMed ID: 17218256
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of ZSTK474, a novel phosphoinositide 3-kinase inhibitor, on osteoclasts and collagen-induced arthritis in mice.
Toyama S; Tamura N; Haruta K; Karakida T; Mori S; Watanabe T; Yamori T; Takasaki Y
Arthritis Res Ther; 2010; 12(3):R92. PubMed ID: 20482767
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
20. Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells.
Saijo S; Asano M; Horai R; Yamamoto H; Iwakura Y
Arthritis Rheum; 2002 Feb; 46(2):533-44. PubMed ID: 11840457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
